Biological Assembly 1  

 3D View: Structure | Electron Density | Ligand Interaction

Standalone Viewers  
Protein Workshop | Ligand Explorer

Global Symmetry: Cyclic - C2  (3D View)
Global Stoichiometry: Homo 2-mer - A2 

Biological assembly 1 assigned by authors and generated by PISA (software)

Macromolecule Content

• Total Structure Weight: 87794.23 
• Atom Count: 6101 
• Residue Count: 774 
• Unique protein chains: 1

1EPV

ALANINE RACEMASE WITH BOUND INHIBITOR DERIVED FROM D-CYCLOSERINE

• DOI: 10.2210/pdb1EPV/pdb

• Classification: ISOMERASE
• Organism(s): Geobacillus stearothermophilus
• Expression System: Escherichia coli


• Deposited: 2000-03-29 Released: 2003-01-14 
• Deposition Author(s): Fenn, T.D., Stamper, G.F., Morollo, A.A., Ringe, D.

---

Experimental Data Snapshot

• Method: X-RAY DIFFRACTION
• Resolution: 2.2 Å
• R-Value Free: 0.226 
• R-Value Work: 0.206 

Literature

A side reaction of alanine racemase: transamination of cycloserine.

Fenn, T.D., Stamper, G.F., Morollo, A.A., Ringe, D.

(2003) Biochemistry 42: 5775-5783

• PubMed: 12741835 
• DOI: 10.1021/bi027022d
• Primary Citation of Related Structures:  
  1NIU


• PubMed Abstract: 
  

Alanine racemase (EC 5.1.1.1) catalyzes the interconversion of alanine enantiomers, and thus represents the first committed step involved in bacterial cell wall biosynthesis. Cycloserine acts as a suicide inhibitor of alanine racemase and as such, serves as an antimicrobial agent. The chemical means by which cycloserine inhibits alanine racemase is unknown. Through spectroscopic assays, we show here evidence of a pyridoxal derivative (arising from either isomer of cycloserine) saturated at the C4' carbon position. We additionally report the L- and D-cycloserine inactivated crystal structures of Bacillus stearothermophilus alanine racemase, which corroborates the spectroscopy via evidence of a 3-hydroxyisoxazole pyridoxamine derivative. Upon the basis of the kinetic and structural properties of both the L- and D-isomers of the inhibitor, we propose a mechanism of alanine racemase inactivation by cycloserine. This pathway involves an initial transamination step followed by tautomerization to form a stable aromatic adduct, a scheme similar to that seen in cycloserine inactivation of aminotransferases.

---

Organizational Affiliation: 

Department of Biochemistry and Chemistry, Rosenstiel Basic Medical Sciences Research Center, Brandeis University, Waltham, Massachusetts 02454, USA.

Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
Molecule	Chains	Sequence Length	Organism	Details
ALANINE RACEMASE	A, B	387	Geobacillus stearothermophilus	Mutation(s): 0  Gene Names: alr (dal) EC: 5.1.1.1
Find proteins for P10724 (Geobacillus stearothermophilus) Go to UniProtKB:  P10724

Small Molecules

Ligands 1 Unique
ID	Chains	Name / Formula / InChI Key	2D Diagram & Interactions
DCS	A, B	D-[3-HYDROXY-2-METHYL-5-PHOSPHONOOXYMETHYL-PYRIDIN-4-YLMETHYL]-N,O-CYCLOSERYLAMIDE D-PYRIDOXYL-N,O-CYCLOSERYLAMIDE-5-MONOPHOSPHATE C11 H16 N3 O7 P NNRZSZJOQKAGTO-SECBINFHSA-N

Modified Residues  1 Unique
ID	Chains	Type	Formula	2D Diagram	Parent
KCX	A, B	L-PEPTIDE LINKING	C7 H14 N2 O4		LYS

Experimental Data & Validation

Experimental Data

• Method: X-RAY DIFFRACTION
• Resolution: 2.2 Å
• R-Value Free: 0.226 
• R-Value Work: 0.206 
• Space Group: P 2₁ 2₁ 2₁

Unit Cell:

Length (Å)	Angle (°)
a = 99.157	α = 90.00
b = 90.243	β = 90.00
c = 85.261	γ = 90.00

Software Package:

Software Name	Purpose
CNS	refinement
SCALEPACK	data scaling
DENZO	data reduction
CNS	phasing

Structure Validation

Entry History 

Deposition Data

• Deposited Date: 2000-03-29 
• Released Date: 2003-01-14 
• Deposition Author(s): Fenn, T.D., Stamper, G.F., Morollo, A.A., Ringe, D.

Revision History 

• Version 1.0: 2003-01-14
  Type: Initial release
• Version 1.1: 2008-04-27
  Type: Version format compliance
• Version 1.2: 2011-07-13
  Type: Version format compliance